GT Biopharma
NAQ: GTBP
$0.24
as on
GT Biopharma Stock Performance
as on September 7, 2026 at 2:16 pm IST
Day's Low
Day's High
$0.22$0.26
8.33%
Downside
8.33%
Upside
52 Week's Low
52 Week's High
$0.22$1.377.46%
Downside
470.83%
Upside
GT Biopharma share price movements today
- Previous Close
- $0.25
- Open
- $0.26
- Volume
- 1.9M
- Market Cap
- $10.9M
- Day's Low - High
- $0.22 - $0.26
- 52 Week Low - High
- $0.22 - $1.37
GT Biopharma Historical Returns
- 1 Month Return
- -24.71 %
- 3 Month Return
- -44.78 %
- 1 Year Return
- -74.5 %
- 3 Year Return
- -97.27 %
- 5 Year Return
- -99.9 %
GT Biopharma Stock Fundamentals & Key Indicators
Check GT Biopharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$10.9M
EPS (TTM)
-0.43
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0Industry PE ratio
-1.61
PEG Ratio
1.0494
EBITDA
-6.8M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-113.52%
GT Biopharma Stock Valuation
Track how GT Biopharma P/E has moved over time to understand its valuation trends.
GT Biopharma in the last 5 years
Lowest (-5.09x)
December 31, 2022
Industry (-1.61x)
September 7, 2026
Today (0.00x)
September 7, 2026
Highest (-0.07x)
June 30, 2026
Today’s Price to Earnings Ratio: 0.00x
GT Biopharma vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of GT Biopharma with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $10.9M | -99.9% | NA | 0.00% | NA | |
| BUY | $44.6B | 614.61% | NA | 0.00% | NA | |
| BUY | $138.4B | 184.14% | 31.53 | 86.04% | NA | |
| BUY | $58.1B | -66.65% | -18.24 | -12.57% | NA | |
| BUY | $85.2B | 23.76% | 19.76 | 84.86% | 0.44999999999999996% |
Stock Returns calculator for GT Biopharma Stock including INR - Dollar returns
The GT Biopharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
GT Biopharma investment value today
Current value as on today
₹27,274
Returns
Returns from GT Biopharma Stock
Dollar Impact
₹1,878 (+1.88%)
Analyst Recommendation on GT Biopharma Stock
Based on 1 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for GT Biopharma. Average target price of $3
GT Biopharma Share Price Target
Get share price movements and forecasts by analysts on GT Biopharma.
What analysts predicted
92%UPSIDE
Target Price
$3
Current Price
$0.24
Analyzed by
1 Analysts
Target
$3.00
GT Biopharma target price $3, a slight upside of 92% compared to current price of $0.24. According to 1 analysts rating.
Indian Investors' Interest in GT Biopharma Stock
Search interest for GT Biopharma Stock has increased by 16% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:16% versus previous 30 day period
GT Biopharma Quarterly Profit & Loss
All numbers in Millions USD
GT Biopharma Annual Profit & Loss
All numbers in Millions USD
GT Biopharma Quarterly Cash Flow
All numbers in Millions USD
GT Biopharma Annual Cash Flow
All numbers in Millions USD
Insights on GT Biopharma
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 34.3% return, outperforming this stock by 131.6%
- NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 479.0% return, outperforming this stock by 553.5%
NEGATIVE IMPACTPrice Dip
In the last 7 days, GTBP stock has moved down by -15.7%
About GT Biopharma
| Organisation | GT Biopharma |
| Headquarters | 315 Montgomery Street, San Francisco, CA, United States, 94104 |
| Industry | Biotechnology |
| CEO | Mr. Michael Martin Breen L.L.B. |
| E-voting on shares | Click here to vote |
Key Management of GT Biopharma
Name | Title |
|---|---|
Mr. Michael Martin Breen L.L.B. | President, CEO & Executive Chairman |
Mr. Alan Louis Urban CPA | CFO & Secretary |
FAQs
What is GT Biopharma share price today?
GT Biopharma share price today is $0.24 as on at the close of the market. GT Biopharma share today touched a day high of $0.26 and a low of $0.22.
What is the 52 week high and 52 week low for GT Biopharma share?
GT Biopharma share touched a 52 week high of $1.37 on and a 52 week low of $0.22 on . GT Biopharma stock price today i.e. is closed at $0.24,which is 82.48% down from its 52 week high and 8.06% up from its 52 week low.
What is GT Biopharma's market capitalisation today?
GT Biopharma market capitalisation is $0.00T as on .
How to invest in GT Biopharma Stock (GTBP) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for GT Biopharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in GT Biopharma Shares that will get you 6.2500 shares as per GT Biopharma share price of $0.24 per share as on September 7, 2026 at 8:46 am IST.
What is the minimum amount required to buy GT Biopharma Stock (GTBP) from India?
Indian investors can start investing in GT Biopharma (GTBP) shares with as little as ₹94.485 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹944.85 in GT Biopharma stock (as per the Rupee-Dollar exchange rate as on ).
Based on GT Biopharma share’s latest price of $0.24 as on September 7, 2026 at 8:46 am IST, you will get 41.6667 shares of GT Biopharma. Learn more about
fractional shares .
What are the returns that GT Biopharma has given to Indian investors in the last 5 years?
GT Biopharma stock has given -99.9% share price returns and 28.66% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?